Contrast (gadolinium) is not routinely required for hand MRI; standard non-contrast scans usually provide excellent detail of bones, tendons, ligaments, and joints. Contrast is reserved for specific problems—suspected infection, tumor, active synovitis, vascular lesions, or poorly defined post-operative changes—to better characterize lesions and inflammation. The need for contrast is decided by the referring clinician and radiologist based on the clinical question.

MRI commonly uses gadolinium-based contrast agents — paramagnetic chelates given intravenously to enhance visualization of blood vessels, inflammation, tumors, and areas where the blood–brain barrier is disrupted. Alternatives (less common) include iron-oxide agents for specific indications. Gadolinium is generally safe but requires kidney-function screening and cautious use in severe renal impairment due to risk of nephrogenic systemic fibrosis.

A right-hand MRI is done by removing jewelry and metal, then placing the arm in a dedicated wrist/hand coil while you lie or sit comfortably. The technologist centers and immobilizes the hand, runs multiple image sequences (T1, T2, PD, fat‑sat), and may use contrast if needed. The exam lasts about 20–45 minutes; you must remain still and follow the technologist’s instructions.

A hand MRI with contrast (gadolinium) typically takes about 30–60 minutes overall. The actual imaging sequences usually last 15–30 minutes; IV placement, contrast injection, pre-scan screening and positioning commonly add 15–30 minutes. Most patients are in the MRI suite for roughly half an hour to an hour; complex studies or scheduling delays can lengthen the visit.

Contrast-enhanced MRI isn’t always required. Gadolinium contrast improves detection and characterization of tumors, infection, inflammation, and vascular abnormalities, so it’s useful when those are suspected or when prior scans are inconclusive. Risks are low for people with normal kidney function but include allergic reactions and rare fibrosis in severe renal failure. Discuss necessity and kidney testing with your clinician.

Most gadolinium-based MRI contrast is filtered and excreted by the kidneys, with about 90% eliminated within 24 hours in people with normal renal function. Small amounts can be retained in brain, bone, and soft tissues for months to years, more likely with certain agent types and in kidney impairment. Patients with severe renal failure have higher retention and risk of complications; discuss agent choice with your radiologist.